August 15, 1974 SUBJECT: An Estim ate of a Safe Detection Level of Asbestos Fiber in Baby Powder Talc.

0 H O F F MA N N - LA R O C H E INC.

s f t aJOHNS-MANVILLE RESuRCH AND ENGINEERING CENTER EXHIBIT VII VW73-62 Tate December 17, 197 MODIFIED FDA OPTICAL FOR ASBESTOS IN TALC 1.

E.

Use, Three,' Optica ( Sysfcetus Obtain ' * Microscopic Profile Of Asbestos And Other Non-Opaque Particulates Larger Than 5 Micrometers In Parenteral Drugs \ by 'e. . .

December S, 1074 Mr.

The Cosmetic, loiietry and Fragrance Association, Inc. 1 1 3 3 1 5 th S T R E E T , N .W ., W A S H IN G T O N , D .C . 2 0 0 0 5 - 2 0 2 / 3 3 1 - 1 7 7 0 T E L E X 8 9 - 2 6 7 3 Jam es H.

f/a '- -.233 ASeptember 20 1971 Ribe.1in Distributors, Inc.

HHs/MG ASB^TOSIS RESEARCH COUNC^ P.O.

P THE UPJOHN COMPANY KALAMAZOO, MICHIGAN 49001 TELEPHONE (616) 382-4000 March iL, 1976 Office of HARRY R ALLEN, M D Manager, FDA Liaison Domestic Pharmaceutical Medical Affairs Hearing Clerk Food and Drug Administration Room L-65 5600 Fishers Lane Rockville, Maryland 20852 Dear Sir: In compliance with Federal Register Notice, Volume Lo, Number 51, March lL, 1975, P&ge 11865, titled "Asbestos-form Particles in Drugs for Parenteral Injection", we are supplying the attached memo.

r UNITED STATES ENVIRO NM ENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 NOV 121973 Ms.

MEMORANDUM OF TELEPHONE CONVERSATION BETOKEN: John Raiggiero Pharmaceutical Manufacturers Association and Paul Fehnel Bureau of Drugs (HFD-30) On February 18, 1976 I received a phone call from Mr.

DUPLICATE j( ^ - ^ r?

FOOD AND DRUG ADMINISTRATION DcU: Jan u ary 28, 1972 RAeUplny otof: BF-1 Subject: Asbestos Activities in the Bureau of Foods per your memorandum of 1/20/72 To: John Jennings, M .D .

MEMORANDUM OF TELEPHONE CONVERSATION March 8, 1976 Between: SUBJECT: John D.